Skip to main content

Edian Health

Edian.ai provides AI-powered decision support tooling for highly regulated life sciences environments, helping expert teams focus on high-value judgment work across clinical trials, regulatory affairs, and manufacturing. The platform is GxP-aligned and 21 CFR Part 11 compliant, with data deployable within the customer's own environment, and delivers co-designed production-ready solutions in as little as two weeks.

Traction –/10
HQ unknown
310+ followers
  • Artificial Intelligence
  • Data & Analytics
  • Software Only
  • Drug Discovery & Therapeutics
  • Enterprise Software
  • Healthcare Technology
Updated 8 days ago

Funding

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Drug development relies on thousands of highly specialized experts whose judgment drives value, yet these professionals are increasingly burdened by data management, documentation, and coordination tasks that consume their time. As portfolios grow and decision cycles shorten, organizations struggle to protect expert bandwidth, leading to delayed programs, paused drug candidates, and slower patient access to effective treatments. Clinical trials have critical timelines where every minute lost to low-value work can jeopardize patient outcomes.

Solution

Edian.ai provides AI-powered decision support tooling designed for highly regulated life sciences environments, enabling expert teams to focus on high-value judgment work. The platform delivers unique tooling that supports fast, accurate decisions and deliverables across sponsor, CRO, and vendor collaboration, clinical trial planning and operations, regulatory intelligence, quality and manufacturing, commercial and market access, and medical affairs. Solutions are co-designed with each organization's workflows and people, then delivered incrementally in as little as two weeks, ensuring easy adoption and measurable results. The system is GxP-aligned and 21 CFR Part 11 compliant, with data safely deployable within the customer's own environment. The platform eliminates administrative work such as reconciling trackers and documentation, allowing teams to scale without hiring and achieve faster timelines than larger organizations.

Target Audience

Primary customers are pharmaceutical and biotechnology companies, contract research organizations (CROs), and life sciences teams with global impact who need to accelerate clinical development, protect expert time, and maintain regulatory compliance. Technology-enabled CROs seeking to deliver on time, quality assurance, and price without compromising patient safety or scientific rigor are also key users.

Features

  • AI-powered decision intelligence that equips decision committees with data-rich go/no-go intelligence for drug candidate programs
  • GxP-aligned architecture with 21 CFR Part 11 compliance and deployment options within the customer's own environment for data security
  • Co-designed solutions tailored to existing workflows, with incremental production-ready delivery in as little as two weeks
  • Support for six functional areas: Sponsor/CRO/Vendor Collaboration, Clinical Trial Planning & Ops, Regulatory Intelligence, Quality & Manufacture, Commercial & Market Access, and Medical Affairs
  • Bespoke software that eliminates manual administrative work including tracker reconciliation and documentation tasks, saving specialists up to a day each week
This profile is AI-generated and may contain inaccuracies.